Access Vascular
MA - BillericaBiotechnology
Focus: Access Vascular develops hydrogel-based venous access devices targeting the cardiovascular market, focusing on midline catheters and PICCs. The company operates as a small, private biotech firm with 1-50 employees based in Billerica, MA.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Employees
1-50
Open Jobs
5
Should You Work at Access Vascular?
AI assessmentBest for early-career or mission-driven professionals seeking device innovation ownership with commercial validation, but carry elevated execution and solvency risk.
Why Work Here
- Early-stage medical device innovation with recent commercial traction: secured Innovative Technology Contract from Vizient (Sept 2026) and distribution deal with Medline (June 2026)
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Hydrophilic Biomaterial Catheter
Midline CatheterHydrophilic Biomaterial PICC
Peripheral ICCHydroPICC
Help build intelligence for Access Vascular
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.